ESG

After years of turmoil, Oregon's only international container terminal reopens, promising economic growth and supply chain resilience for the region.

A new partnership integrates whole-genome sequencing into a clinical trial for a novel cancer drug, promising to accelerate development and usher in a new era.

As costs rise, a new $35M grant program will fund 70 nonprofits working to stabilize and strengthen finances for low-income American families.

After reporting huge preliminary profit and revenue growth, Sagtec unveils a bold 2026 strategy focused on AI platforms, EV subscriptions, and ESG tech.

Over 60% of cats and 59% of dogs are overweight, a silent crisis shortening lives. Vets warn against risky shortcuts and urge proactive, guided care.

A new grant funds a radical approach using AI and postmortem human brains to find crucial clues for Parkinson's therapies, aiming to crack a major medical challenge.

A $9.7M joint investment will fast-track a perpetual robot, low-carbon cement, and tech to remove 'forever chemicals' from water.

Ag-tech leader Agerpoint appoints Michael Gomes to embed its AI and digital twin tech directly into farm machinery, signaling a major industry shift.

With a new $7.5M investment, Elysium Therapeutics is advancing SOOPR, a long-acting overdose rescue agent designed to combat the deadly fentanyl rebound.

A landmark FDA decision allows Life Biosciences to test its epigenetic reprogramming therapy, ER-100, offering new hope for restoring sight in the blind.

As drug-resistant fungi pose a grave threat, SCYNEXIS presents promising data on SCY-247, a next-gen drug that could redefine the fight against infection.

A new SoHo wellness hub uses invisible tech and EEG sensors to read your mind and adapt its environment. But is this the future or a privacy nightmare?

Premier Radiology Services’ acquisition of NRAD marks its third major deal, amplifying a private equity-fueled consolidation trend in the teleradiology market.

With promising brain scan data, a deep therapeutic pipeline, and a cash runway into 2027, Radiopharm Theranostics is gaining significant momentum.

A new study in Nature Medicine shows a fasting-mimicking diet led to high remission rates in Crohn's patients, heralding a new era for 'Food as Medicine'.

A new US-Japan mission aims to create unhackable communication from space using quantum tech, placing Terran Orbital at the center of a new space race.

A historic wave of business acquisitions is set to reshape Canada's economy as owners retire, unlocking immense profits for savvy buyers.

Travel is no longer just about the destination. In 2026, AI-powered planning and a thirst for authentic experiences are reshaping vacations worldwide.

Finnish firm GlucoModicum publishes research validating its needle-free tech, a major step toward ending painful finger pricks for diabetes management.

While traditional property languishes, Finland's real estate market is being reshaped by a digital gold rush and a Lapland tourism boom. Here's why.